Stay updated on Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial
Sign up to get notified when there's something new on the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page.

Latest updates to the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe Study Record Versions history now lists Revision: v3.6.5 as the latest release, replacing the previous v3.6.4 entry.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe record history now includes a new revision entry for v3.6.4 and removes the previous v3.6.3 entry. This indicates an update to the platform's release notes linked to the study record.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry, Revision: v3.6.3, was added to the study record history, updating the latest version from v3.6.2. This reflects an update to the study record's metadata in the history log.SummaryDifference0.1%

- Check52 days agoChange DetectedA new release entry, v3.6.2, was added to the Record History and the older v3.6.0 entry was removed, reflecting an update to the site's version history.SummaryDifference0.1%

- Check67 days agoChange DetectedRecruitment is now shown as closed to participants, and the history includes a new Revision: v3.6.0 while removing Revision: v3.5.5.SummaryDifference0.6%

- Check74 days agoChange DetectedVersion 6 updates the study record with revisions to core sections (Study Status, Recruitment Status, Eligibility, Arms and Interventions, Conditions, Study Description) and adds new sections (Outcome Measures), labeled v3.5.5 on 2026-05-28 (with related changes on 2026-05-27). The previous status (Active, not recruiting) was removed and the prior revision (v3.5.4) is replaced.SummaryDifference2%

Stay in the know with updates to Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page.